Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid and Melatonin in Immediate Dental Implants
NCT03692026Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of hyaluronic acid sodium composite gel for injection and Mucomel in tooth loss, sponsored by Cairo University. Primary endpoint: Implant Stability Quotient at 6 months. Status: unknown.
02
Drugs
hyaluronic acid sodium composite gel for injectionMucomel
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT03692026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03692026.